Gene Kinney

Gene Kinney

Chief Executive Officer at PROTHENA CORPORATION PLC

Net worth: 266 222 $ as of 2024-05-30

55 year
Health Technology
Consumer Services

Profile

Gene G.
Kinney
's current job is President, Chief Executive Officer & Director at Prothena Corp.
Plc.
Formerly, he worked as Senior Director-Central Pharmacology at Merck Research Laboratories Massachusetts LLC from 2001 to 2009.
He also served as an Assistant Professor at Emory University School of Medicine.
From 2009 to 2012, he held the position of Senior Vice President-Pharmacological Sciences at Elan Pharmaceuticals LLC.
Additionally, he was the Head-Nonclinical Research at Janssen Alzheimer Immunotherapy from 2009 to 2012.
In terms of education, Dr. Kinney completed his undergraduate degree at Bloomsburg University of Pennsylvania.
He then pursued graduate and doctorate degrees at Florida Atlantic University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-03 12,793 ( 0.02% ) 266 222 $ 2024-05-30

Gene Kinney active positions

CompaniesPositionStart
PROTHENA CORPORATION PLC Chief Executive Officer 2016-09-29
All active positions of Gene Kinney

Former positions of Gene Kinney

CompaniesPositionEnd
Corporate Officer/Principal 2012-11-30
Janssen Alzheimer Immunotherapy Corporate Officer/Principal 2012-09-30
Corporate Officer/Principal 2008-12-31
Emory University School of Medicine Corporate Officer/Principal -
See the detail of Gene Kinney's experience

Training of Gene Kinney

Bloomsburg University of Pennsylvania Undergraduate Degree
Florida Atlantic University Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gene Kinney's experience

Connections

86

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
PROTHENA CORPORATION PLC

Health Technology

Private companies3

Health Technology

Health Technology

Janssen Alzheimer Immunotherapy

See company connections